Lexiva Related Clinical Trials
A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects [Completed]
Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects [Recruiting]
HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir [Recruiting]
Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects [Recruiting]
Fosamprenavir Expanded Access [No longer available]
KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks [Completed]
GSK1349572 Drug Interaction Study With Fosamprenavir/Ritonavir [Recruiting]
Fosamprenavir Versus Other Protease Inhibitors [Completed]
Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects [Terminated]
A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects [Active, not recruiting]
Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir [Recruiting]
Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir) [Completed]
48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection [Recruiting]
A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years [Recruiting]
Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA) [Recruiting]
Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR [Completed]
Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure [Active, not recruiting]
Co-Administration Of Fosamprenavir With Methadone: A Drug Interaction Study. [Completed]
Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications [Recruiting]
"The Once A Day Protease Inhibitor Regimens" [Active, not recruiting]
HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults [Recruiting]
An Interaction Study to Assess Drug Levels in Fasting Healthy Adult Subjects [Recruiting]
Plasma Amprenavir In HIV-1-Infected Adult Subjects With Liver Function Impairment [Recruiting]
Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy [Active, not recruiting]
Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs [Active, not recruiting]
A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination [Active, not recruiting]
Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People [Completed]
A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT [Recruiting]
A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir [Recruiting]
Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r [Recruiting]
Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients [Completed]
Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-Term Observational Study [Recruiting]
Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV [Recruiting]
MARCH Central Nervous System Substudy [Recruiting]
MARCH Renal Substudy [Recruiting]
An Interaction Study to Assess Drug Levels in Healthy Adult Subjects [Completed]
An Interaction Study to Assess Drug Levels in Healthy Adult Subjects [Recruiting]
Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects [Recruiting]
Maraviroc Switch Collaborative Study [Recruiting]
Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-Resistant HIV [Active, not recruiting]
Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents [Recruiting]
Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients [Recruiting]
MARCH Vascular Endothelium Substudy [Recruiting]
Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents [Recruiting]
Pharmacokinetic Study of Anti-HIV Drugs During Pregnancy [Recruiting]
Clinical Trial of CNS-targeted HAART (CIT2) [Recruiting]
IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5 Inhibitor On The Lymphoid Reservoir For Hiv-1 In Chronically Infected Patients [Recruiting]
Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects [Recruiting]
Pilot Opened Trial in HIV-Infected Patients Including an Investigational Marketed Product [Recruiting]
|
